日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

A phase 1 study of the amino acid modulator pegcrisantaspase and venetoclax for relapsed or refractory acute myeloid leukemia

一项针对复发或难治性急性髓系白血病的氨基酸调节剂pegcrisantaspase和venetoclax的I期研究

Liu, Yuchen; Bollino, Dominique R; Bah, Osman M; Strovel, Erin T; Le, Tien V; Zarrabi, Jinoos; Philip, Sunita; Lapidus, Rena G; Baer, Maria R; Niyongere, Sandrine; Duong, Vu H; Dougherty, Christine C; Beumer, Jan H; Caprinolo, Katherine D; Kamangar, Farin; Emadi, Ashkan

Rational design of flavivirus E protein vaccine optimizes immunogenicity and mitigates antibody dependent enhancement risk.

黄病毒E蛋白疫苗的合理设计可优化免疫原性并降低抗体依赖性增强风险。

Wang Yimeng, Galkin Andrey, Shang Xiaoran, Marin Alexander, Jin Shaohua, Ye Ting-Juan, Bale Shridhar, Chiang Chi-I, Chowdhury Ananda, Chenine Agnes L, Turonis Ashley, Greenhouse Jack, Stone Rebecca, Wear Jaclyn, Kar Swagata, Andersen Hanne, Huang Yan-Jang S, Vanlandingham Dana L, Higgs Stephen, Lapidus Rena G, Fuerst Thomas, Weber David J, Wyatt Richard T, Iffland Christel, Pierson Theodore C, Andrianov Alexander K, Pozharski Edwin, Li Yuxing

Evaluation of co‑inhibition of ErbB family kinases and PI3K for HPV‑negative head and neck squamous cell carcinoma

评估ErbB家族激酶和PI3K共抑制对HPV阴性头颈部鳞状细胞癌的疗效

Geng, Xinyan; Azarbarzin, Shirin; Yang, Zejia; Lapidus, Rena G; Fan, Xiaoxuan; Teng, Yong; Mehra, Ranee; Cullen, Kevin J; Dan, Hancai

Extracellular vesicle PD-L1 dynamics predict durable response to immune-checkpoint inhibitors and survival in patients with non-small cell lung cancer

细胞外囊泡PD-L1动态变化可预测非小细胞肺癌患者对免疫检查点抑制剂的持久反应和生存期

de Miguel-Perez, Diego; Russo, Alessandro; Arrieta, Oscar; Ak, Murat; Barron, Feliciano; Gunasekaran, Muthukumar; Mamindla, Priyadarshini; Lara-Mejia, Luis; Peterson, Christine B; Er, Mehmet E; Peddagangireddy, Vishal; Buemi, Francesco; Cooper, Brandon; Manca, Paolo; Lapidus, Rena G; Hsia, Ru-Ching; Cardona, Andres F; Naing, Aung; Kaushal, Sunjay; Hirsch, Fred R; Mack, Philip C; Serrano, Maria Jose; Adamo, Vincenzo; Colen, Rivka R; Rolfo, Christian

Phase I Clinical Trial of DNA Methyltransferase Inhibitor Decitabine and PARP Inhibitor Talazoparib Combination Therapy in Relapsed/Refractory Acute Myeloid Leukemia.

DNA甲基转移酶抑制剂地西他滨和PARP抑制剂他拉唑帕尼联合治疗复发/难治性急性髓系白血病的I期临床试验

Baer Maria R, Kogan Aksinija A, Bentzen Søren M, Mi Tian, Lapidus Rena G, Duong Vu H, Emadi Ashkan, Niyongere Sandrine, O'Connell Casey L, Youngblood Benjamin A, Baylin Stephen B, Rassool Feyruz V

Antileukemic efficacy of a potent artemisinin combined with sorafenib and venetoclax

强效青蒿素联合索拉非尼和维奈托克治疗白血病的疗效

Moses, Blake S; McCullough, Samantha; Fox, Jennifer M; Mott, Bryan T; Bentzen, Søren M; Kim, MinJung; Tyner, Jeffrey W; Lapidus, Rena G; Emadi, Ashkan; Rudek, Michelle A; Kingsbury, Tami J; Civin, Curt I

Pulsed focused ultrasound lowers interstitial fluid pressure and increases nanoparticle delivery and penetration in head and neck squamous cell carcinoma xenograft tumors

脉冲聚焦超声可降低组织间液压力,并增加纳米颗粒在头颈部鳞状细胞癌异种移植瘤中的递送和渗透。

Mohammadabadi, Ali; Huynh, Ruby N; Wadajkar, Aniket S; Lapidus, Rena G; Kim, Anthony J; Raub, Christopher B; Frenkel, Victor

Equipotent doses of daunorubicin and idarubicin for AML: a meta-analysis of clinical trials versus in vitro estimation

柔红霉素和伊达比星治疗急性髓系白血病的等效剂量:临床试验与体外估算的荟萃分析

Adige, Sunil; Lapidus, Rena G; Carter-Cooper, Brandon A; Duffy, Alison; Patzke, Ciera; Law, Jennie Y; Baer, Maria R; Ambulos, Nicholas P; Zou, Ying; Bentzen, Søren M; Emadi, Ashkan

Gamma Delta T Cell Therapy for Cancer: It Is Good to be Local

γδT细胞疗法治疗癌症:本地化治疗效果更佳

Pauza, C David; Liou, Mei-Ling; Lahusen, Tyler; Xiao, Lingzhi; Lapidus, Rena G; Cairo, Cristiana; Li, Haishan

Synthesis, characterization and antineoplastic activity of bis-aziridinyl dimeric naphthoquinone - A novel class of compounds with potent activity against acute myeloid leukemia cells

双氮丙啶二聚萘醌的合成、表征及其抗肿瘤活性——一类对急性髓系白血病细胞具有强效活性的新型化合物

Carter-Cooper, Brandon A; Fletcher, Steven; Ferraris, Dana; Choi, Eun Yong; Kronfli, Dahlia; Dash, Smaraki; Truong, Phuc; Sausville, Edward A; Lapidus, Rena G; Emadi, Ashkan